Third line therapy in metastatic renal cell carcinoma (mRCC): results from the international mRCC database consortium (IMDC)

被引：0

作者：

Stukalina, Igor ^{[1
]}

Wellsa, J. Connor ^{[2
]}

Donskovb, Frede ^{[3
]}

Rinic, Brian I. ^{[4
]}

Leed, Jae-Lyun ^{[5
]}

Bjarnasone, Georg A. ^{[6
]}

Beuselinckf, Benoit ^{[7
]}

Smoragiewicz, Martin ^{[8
]}

Alvah, Ajjai Shivaram ^{[9
]}

Srinivasi, Sandy ^{[10
]}

Woodi, Lori ^{[11
]}

Saleemk, Sadia ^{[12
]}

Pal, Sumanta Kumar ^{[1
]}

Yuasam, Takeshi ^{[13
]}

Broomn, Reuben James ^{[14
]}

Kanesvaran, Ravindran ^{[15
]}

Bamiasp, Aristotelis ^{[16
]}

Knoxq, Jennifer J. ^{[17
]}

Henga, Daniel Y. C. ^{[18
]}

Choueirir, Toni K. ^{[18
]}

机构：

[1] Tom Baker Canc Clin, Calgary, AB, Canada

[2] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark

[3] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[4] Asan Med Ctr, Seoul, South Korea

[5] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada

[6] Univ Hosp Leuven, Leuven, Belgium

[7] BC Canc Agcy, Vancouver, BC, Canada

[8] Univ Michigan, Ann Arbor, MI 48109 USA

[9] Stanford Med Ctr, Stanford, CA USA

[10] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada

[11] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA

[12] City Hope Natl Med Ctr, Duarte, CA 91010 USA

[13] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan

[14] Auckland City Hosp, Auckland, New Zealand

[15] Natl Canc Ctr Singapore, Singapore, Singapore

[16] Univ Athens, Athens 11528, Greece

[17] Princess Margaret Canc Ctr, Toronto, ON, Canada

[18] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

BJU INTERNATIONAL | 2015年 / 116卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：21 / 21

页数：1

共 50 条

[21] Outcomes of first-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
Gan, Chun Loo
Dudani, Shaan
Wells, Connor J.
Schmidt, Andrew Lachlan
Bakouny, Ziad
Szabados, Bernadett
Parnis, Francis
Wong, Shirley
Lee, Jae-Lyun
de Velasco, Guillermo
Pal, Sumanta K.
Davis, Ian D.
Kanesvaran, Ravindran
Wood, Lori
Kollmannsberger, Christian K.
McKay, Rana R.
Beuselinck, Benoit
Donskov, Frede
Choueiri, Toni K.
Heng, Daniel Yick Chin
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
[22] Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC).
Ferrier, Evan
Lemelin, Audreylie
Powles, Thomas
Pal, Sumanta Kumar
Ebrahimi, Hedyeh
Agarwal, Neeraj
Beuselinck, Benoit
Bjarnason, Georg A.
Wood, Lori
Canil, Christina M.
Saliby, Renee Maria
de Velasco, Guillermo
Mckay, Rana R.
Tran, Ben
Suarez, Cristina
Templeton, Arnoud J.
Choueiri, Toni K.
Heng, Daniel Yick Chin
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 395 - 395
[23] Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC)-an International mRCC Database Consortium (IMDC) analysis
Araujo, Daniel, V
Wells, J. Connor
Hansen, Aaron R.
Dizman, Nazli
Pal, Sumanta K.
Beuselinck, Benoit
Donskov, Frede
Gan, Chun L.
Yan, Flora
Tran, Ben
Kollmannsberger, Christian K.
de Velasco, Guillermo
Yuasa, Takeshi
Reaume, M. Neil
Ernst, D. Scott
Powles, Thomas
Bjarnason, Georg A.
Choueiri, Toni K.
Heng, Daniel Y. C.
Dudani, Shaan
[J]. JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (05) : 820 - 826
[24] Impact of bone and liver metastases (BM, LM) in patients with metastatic renal cell carcinoma (mRCC) treated with molecularly targeted agents (MTAs): Results from the International mRCC Database Consortium (IMDC)
McKay, Rana R.
Kroeger, Nils
Xie, Wanling
Lee, Jae-Lyun
Knox, Jennifer J.
Bjarnason, Georg A.
MacKenzie, Mary J.
Wood, Lori
Srinivas, Sandy
Vaishampayan, Ulka N.
Rha, Sun Young
Pal, Sumanta Kumar
Donskov, Frede
Tantravahi, Srinivas
Rini, Brian I.
Heng, Daniel Yick Chin
Choueiri, Toni K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
[25] The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model as a prognostic tool in metastatic renal cell carcinoma (mRCC) patients previously treated with first-line targeted therapy (TT)
Ko, Jenny J.
Xie, Wanling
Heng, Daniel Yick Chin
Kroeger, Nils
Lee, Jae-Lyun
Rini, Brian I.
Knox, Jennifer J.
Bjarnason, Georg A.
Harshman, Lauren Christine
Pal, Sumanta Kumar
Yuasa, Takeshi
Smoragiewicz, Martin
Donskov, Frede
Bamias, Aristotelis
Wood, Lori
Ernst, D. Scott
Agarwal, Neeraj
Vaishampayan, Ulka N.
Rha, Sun Young
Choueiri, Toni K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
[26] Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC): An international mRCC database consortium (IMDC) analysis.
Araujo, Daniel Vilarim
Wells, Connor
Hansen, Aaron Richard
Dizman, Nazli
Pal, Sumanta K.
Beuselinck, Benoit
Donskov, Frede
Gan, Chun Loo
Yan, Flora
Tran, Ben
Kollmannsberger, Christian K.
de Velasco, Guillermo
Yuasa, Takeshi
Reaume, M. Neil
Ernst, D. Scott
Powles, Thomas
Bjarnason, Georg A.
Choueiri, Toni K.
Heng, Daniel Yick Chin
Dudani, Shaan
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[27] First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
Roussel, Eduard
Kinget, Lisa
Beuselinck, Benoit
Albersen, Maarten
Wells, Connor
Ernst, Matthew Scott
Donskov, Frede
Schmidt, Andrew Lachlan
Szabados, Bernadett
Pal, Sumanta K.
Meza, Luis A.
Agarwal, Neeraj
Weickhardt, Andrew James
Davis, Ian D.
Alva, Ajjai Shivaram
Wood, Lori
Porta, Camillo
Choueiri, Toni K.
Heng, Daniel Yick Chin
Navani, Vishal
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[28] First-line (1L) immuno-oncology (10) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
Dudani, Shaan
Graham, Jeffrey
Wells, Connor
Pal, Sumanta K.
Dizman, Nazli
Donskov, Frede
Bjarnason, Georg A.
Hansen, Aaron Richard
Iafolla, Marco Adelmo James
Vaishampayan, Ulka N.
Porta, Camillo
Beuselinck, Benoit
Yan, Flora
Wood, Lori
Liow, Elizabeth Chien Hern
Kollmannsberger, Christian K.
Yuasa, Takeshi
Zhang, Chiyuan A.
Choueiri, Toni K.
Heng, Daniel Yick Chin
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
[29] Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma (mRCC) treated with targeted therapy: Results from the International mRCC Database Consortium
Xie, Wanling
Choueiri, Toni K.
Lee, Jae-Lyun
Harshman, Lauren Christine
Bjarnason, Georg A.
Knox, Jennifer J.
MacKenzie, Mary J.
Wood, Lori
Vaishampayan, Ulka N.
Yuasa, Takeshi
Tan, Min-Han
Rha, Sun Young
Donskov, Frede
Agarwal, Neeraj
Kollmannsberger, Christian K.
North, Scott A.
Rini, Brian I.
Heng, Daniel Yick Chin
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[30] The impact of impaired renal function on the effectiveness of first-line immuno-oncology combination therapies in metastatic renal cell carcinoma (mRCC): Results from the international metastatic RCC database consortium (IMDC)
Navani, V.
Ernst, M. S.
Takemura, K.
Pal, S. K.
Powles, T. B.
Donskov, F.
Wells, J. C.
Kollmannsberger, C. K.
Beuselinck, B.
Alva, A. S.
Weickhardt, A. J.
Lalani, A-K.
Ernst, D. S.
Agarwal, N.
Choueiri, T. K.
Heng, D. Y. C.
[J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1215 - S1216

← 1 2 3 4 5 →